PBA
Paradigm Biocapital Advisors’s Olema Pharmaceuticals OLMA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.8M | Buy |
6,764,172
+23,000
| +0.3% | +$98K | 1.23% | 22 |
|
|
2025
Q1 | $25.3M | Sell |
6,741,172
-563,798
| -8% | -$2.12M | 1.16% | 21 |
|
|
2024
Q4 | $42.6M | Buy |
7,304,970
+1,801,370
| +33% | +$10.5M | 1.48% | 16 |
|
|
2024
Q3 | $65.7M | Sell |
5,503,600
-2,400,000
| -30% | -$28.7M | 2.22% | 14 |
|
|
2024
Q2 | $85.5M | Hold |
7,903,600
| – | – | 3.27% | 12 |
|
|
2024
Q1 | $89.5M | Hold |
7,903,600
| – | – | 3.15% | 14 |
|
|
2023
Q4 | $111M | Buy |
7,903,600
+100,000
| +1% | +$1.4M | 5.19% | 6 |
|
|
2023
Q3 | $96.4M | Buy |
7,803,600
+4,072,554
| +109% | +$50.3M | 6.54% | 4 |
|
|
2023
Q2 | $33.7M | Buy |
3,731,046
+1,348,669
| +57% | +$12.2M | 2.6% | 16 |
|
|
2023
Q1 | $8.27M | Buy |
+2,382,377
| New | +$8.27M | 0.78% | 24 |
|